- Research works
- 2 fractional, all time
- Citations
- 15 8.9 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 72% world 28%
Not ranked overall: Pharmanest (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Pharmanest (Sweden) publish most on?
By volume in 2022–2025: Birth, Development, and Health, Diet and metabolism studies, Diet, Metabolism, and Disease and Liver Disease Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Birth, Development, and Health Pediatrics, Perinatology and Child Health 0 works
- 2 Diet and metabolism studies Physiology 0 works
- 3 Diet, Metabolism, and Disease Endocrinology, Diabetes and Metabolism 0 works
- 4 Liver Disease Diagnosis and Treatment Epidemiology 0 works
- 5 Liver physiology and pathology Hepatology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pharmanest (Sweden)'s research output changed?
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Solna
- Bristol-Myers Squibb (Sweden)
- Abbott (Sweden)
- Public Health Agency of Sweden
- Stockholm International Peace Research Institute
- Swedish Space Corporation
- Radium Hemmets Research Funds
- Johnson & Johnson (Sweden)
- Karolinska Development (Sweden)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.